Toronto - Delayed Quote CAD

Medexus Pharmaceuticals Inc. (MDP.TO)

Compare

4.0400

-0.0300

(-0.74%)

At close: January 10 at 4:00:00 PM EST

Currency in USD All numbers in thousands

Download

Breakdown

TTM

3/31/2024

3/31/2023

3/31/2022

3/31/2021

Total Revenue

104,759.0000

113,054.0000

108,096.0000

76,701.0000

79,660.0000

Cost of Revenue

49,800.0000

53,540.0000

48,058.0000

38,774.0000

37,655.0000

Gross Profit

54,959.0000

59,514.0000

60,038.0000

37,927.0000

42,005.0000

Operating Expense

42,136.0000

46,727.0000

51,549.0000

50,303.0000

41,274.0000

Operating Income

12,823.0000

12,787.0000

8,489.0000

-12,376.0000

731.0000

Net Non Operating Interest Income Expense

-9,074.0000

-13,364.0000

-13,606.0000

-12,223.0000

-9,816.0000

Other Income Expense

-2,235.0000

683.0000

76.0000

20,779.0000

-22,416.0000

Pretax Income

1,514.0000

106.0000

-5,041.0000

-3,820.0000

-31,501.0000

Tax Provision

-781.0000

320.0000

-6,262.0000

-941.0000

-3,237.0000

Net Income Common Stockholders

2,295.0000

-214.0000

1,221.0000

-2,879.0000

-28,264.0000

Diluted NI Available to Com Stockholders

2,295.0000

-214.0000

1,221.0000

-2,879.0000

-28,264.0000

Basic EPS

0.09

-0.01

0.06

-0.15

-1.86

Diluted EPS

0.09

-0.01

0.06

-0.15

-1.86

Basic Average Shares

24,407.0990

22,321.4460

19,976.1670

19,454.1550

15,197.4190

Diluted Average Shares

24,572.3800

22,486.7270

20,523.8040

19,855.7940

15,197.4190

Total Operating Income as Reported

8,011.0000

10,794.0000

7,614.0000

-14,996.0000

-1,376.0000

Total Expenses

91,936.0000

100,267.0000

99,607.0000

89,077.0000

78,929.0000

Net Income from Continuing & Discontinued Operation

2,295.0000

-214.0000

1,221.0000

-2,879.0000

-28,264.0000

Normalized Income

4,194.7500

-794.5500

1,175.4000

-18,539.4034

-8,151.4377

Interest Income

3.0000

Interest Expense

9,074.0000

13,364.0000

13,606.0000

12,223.0000

9,816.0000

Net Interest Income

-9,074.0000

-13,364.0000

-13,606.0000

-12,223.0000

-9,816.0000

EBIT

10,588.0000

13,470.0000

8,565.0000

8,403.0000

-21,685.0000

EBITDA

16,471.0000

19,276.0000

14,646.0000

14,548.0000

-15,707.0000

Reconciled Cost of Revenue

44,154.0000

47,985.0000

42,330.0000

33,027.0000

32,183.0000

Reconciled Depreciation

5,883.0000

5,806.0000

6,081.0000

6,145.0000

5,978.0000

Net Income from Continuing Operation Net Minority Interest

2,295.0000

-214.0000

1,221.0000

-2,879.0000

-28,264.0000

Total Unusual Items Excluding Goodwill

-2,235.0000

683.0000

76.0000

20,779.0000

-22,416.0000

Total Unusual Items

-2,235.0000

683.0000

76.0000

20,779.0000

-22,416.0000

Normalized EBITDA

18,706.0000

18,593.0000

14,570.0000

-6,231.0000

6,709.0000

Tax Rate for Calcs

0.0002

0.0004

0.0002

0.0001

Tax Effect of Unusual Items

-335.2500

102.4500

30.4000

5,118.5966

-2,303.4377

3/31/2021 - 1/9/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

CPH.TO Cipher Pharmaceuticals Inc.

14.28

-3.12%

SBBC.V Simply Better Brands Corp.

1.0800

-0.92%

CRDL.TO Cardiol Therapeutics Inc.

1.8600

-2.11%

HLS.TO HLS Therapeutics Inc.

3.8100

-1.04%

HASH.V SIMPLY SOLVENTLESS CONCENTRATES

0.7000

+1.45%

RVVTF Revive Therapeutics Ltd.

0.0060

-4.76%

MOB.ST Moberg Pharma AB (publ)

9.36

-4.00%

PHRX.CN Pharmadrug Inc.

0.0150

0.00%

DHT-UN.TO DRI Healthcare Trust

11.96

-2.13%

SCYX SCYNEXIS, Inc.

1.2300

0.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Medexus Pharmaceuticals Inc. (MDP.TO)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers